drugset / Trial / NCT01877265
A Study of LY2605541 in Healthy Participants
RandomizedCrossoverDouble-blindBasic science
Summary
This study looks at the amount of LY2605541 in the body after it is injected under the skin. The study has 3 periods, each lasting 10 days. Each participant will receive one injection in each period. At least 14 days will pass between each injection.
Timeline
- Start
- 2013-06
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin Peglispro | Protein / enzyme biologic | 0.5 iu/kg | Subcutaneous |
Indications
No indication recorded.